Kestra Medical Technologies (KMTS) Interest Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Interest Expenses data on file, last reported at $1.9 million in Q1 2026.

• Quarterly Interest Expenses rose 5.89% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $7.5 million (down 5.66% YoY) and the FY2025 annual result came in at $7.7 million, up 24.14% from the prior year.
• Interest Expenses eased to $1.9 million in Q1 2026 per KMTS's latest filing, from $1.9 million in the prior quarter.
• Across five years, Interest Expenses topped out at $2.3 million in Q4 2024 and bottomed at $1.7 million in Q1 2024.
• The 3-year median for Interest Expenses is $1.9 million (2026), against an average of $1.9 million.
• Peak annual rise in Interest Expenses reached 8.0% in 2025, while the deepest fall reached 17.95% in 2025.
• Tracing KMTS's Interest Expenses over 3 years: stood at $2.3 million in 2024, then fell by 17.95% to $1.9 million in 2025, then slipped by 0.68% to $1.9 million in 2026.
• Per Business Quant, the three latest KMTS Interest Expenses figures stand at $1.9 million (Q1 2026), $1.9 million (Q4 2025), and $1.9 million (Q3 2025).

Peer Comparison